The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
FXR signaling in the enterohepatic system
Open accessAbstract
Enterohepatic circulation serves to capture bile acids and other steroid metabolites produced in the liver and secreted to the intestine, for reabsorption back into the circulation and reuptake to the liver. This process is under tight regulation by nuclear receptor signaling. Bile acids, produced from cholesterol, can alter gene expression in the liver and small intestine via activating the nuclear receptors farnesoid X receptor (FXR; NR1H4), pregnane X receptor (PXR; NR1I2), vitamin D receptor (VDR; NR1I1), G protein coupled receptor TGR5, and other cell signaling pathways (JNK1/2, AKT and ERK1/2). Among these controls, FXR is known to be a major bile acid-responsive ligand-activated transcription factor and a crucial control element for maintaining bile acid homeostasis. FXR has a high affinity for several major endogenous bile acids, notably cholic acid, deoxycholic acid, chenodeoxycholic acid, and lithocholic acid. By responding to excess bile acids, FXR is a bridge between the liver and small intestine to control bile acid levels and regulate bile acid synthesis and enterohepatic flow. FXR is highly expressed in the liver and gut, relative to other tissues, and contributes to the maintenance of cholesterol/bile acid homeostasis by regulating a variety of metabolic enzymes and transporters. FXR activation also affects lipid and glucose metabolism, and can influence drug metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Self-citationEndogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487
Identification of a nuclear receptor that is activated by farnesol metabolites
Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · cited 1×
“After administration of GW4064 to BDL mice, bacterial overgrowth in the ileum and cecum is completely blocked (Inagaki et al., 2006).”
MethodStrautnieks, S. S., Bull, L. N., Knisely, A. S., Kocoshis, S. A., Dahl, N., Arnell, H., Sokal, E., Dahan, K., Childs, S., Ling, V., et al. (1998) · Nature Genetics · doi:10.1038/3034 · Cited by 995
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 953
Self-citationGadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870 · cited 4×
“6-ECDCA, also known as INT-747, is another efficacious FXR agonist under testing for various diseases associated with bile acid dysfunction, such as liver fibrosis (Fiorucci et al., 2004) and inflammatory bowel disease (Gadaleta et al., 2011).”
BackgroundInfluentialvan Helvoort, A., Smith, A. J., Sprong, H., Fritzsche, I., Schinkel, A. H., Borst, P., & van Meer, G. (1996) · Cell · doi:10.1016/s0092-8674(00)81370-7 · Cited by 855
Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J., & Suchy, F. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011610200 · Cited by 801
Pellicciari, R., Fiorucci, S., Camaioni, E., Clerici, C., Costantino, G., Maloney, P. R., Morelli, A., Parks, D. J., & Willson, T. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025529g · Cited by 743
Mutations in the MDR 3 gene cause progressive familial intrahepatic cholestasis
de Vree, J. M. L., Jacquemin, E., Sturm, E., Cresteil, D., Bosma, P. J., Aten, J., Deleuze, J.-F., Desrochers, M., Burdelski, M., Bernard, O., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.282 · Cited by 735
Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K. F., Donahee, M., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 696
The bile acid receptor FXR is a modulator of intestinal innate immunity
Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803978 · Cited by 655
FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
Kir, S., Beddow, S. A., Samuel, V. T., Miller, P., Previs, S. F., Suino-Powell, K., Xu, H. E., Shulman, G. I., Kliewer, S. A., & Mangelsdorf, D. J. (2011) · Science · doi:10.1126/science.1198363 · Cited by 637
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S. A., & Gonzalez, F. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 592
Self-citationA Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR
Urizar, N. L., Liverman, A. B., Dodds, D. T., Silva, F. V., Ordentlich, P., Yan, Y., Gonzalez, F. J., Heyman, R. A., Mangelsdorf, D. J., & Moore, D. D. (2002) · Science · doi:10.1126/science.1072891 · Cited by 549
Self-citationIdentification of a Chemical Tool for the Orphan Nuclear Receptor FXR
Maloney, P. R., Parks, D. J., Haffner, C. D., Fivush, A. M., Chandra, G., Plunket, K. D., Creech, K. L., Moore, L. B., Wilson, J. G., Lewis, M. C., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002127 · Cited by 527
Yang, F., Huang, X., Yi, T., Yen, Y., Moore, D. D., & Huang, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1078 · Cited by 488
Fiorucci, S., Antonelli, E., Rizzo, G., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pellicciari, R., & Morelli, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.001 · Cited by 472
Hagenbuch, B., & Meier, P. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117091 · Cited by 464
Denson, L. A., Sturm, E., Echevarria, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., & Karpen, S. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.25503 · Cited by 460
Kong, B., Wang, L., Chiang, J. Y. L., Zhang, Y., Klaassen, C. D., & Guo, G. L. (2012) · Hepatology · doi:10.1002/hep.25740 · Cited by 456
FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway
Potthoff, M. J., Boney-Montoya, J., Choi, M., He, T., Sunny, N. E., Satapati, S., Suino-Powell, K., Xu, H. E., Gerard, R. D., Finck, B. N., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.019 · Cited by 431
Cipriani, S., Mencarelli, A., Palladino, G., & Fiorucci, S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m001602 · Cited by 416
Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · PubMed · Cited by 408
Liu, Y., Binz, J., Numerick, M. J., Dennis, S., Luo, G., Desai, B., MacKenzie, K. I., Mansfield, T. A., Kliewer, S. A., Goodwin, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18945 · Cited by 398
Seol, W. (1995) · Molecular Endocrinology · doi:10.1210/me.9.1.72 · Cited by 393
A Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXR
Downes, M., Verdecia, M. A., Roecker, A. J., Hughes, R., Hogenesch, J. B., Kast-Woelbern, H. R., Bowman, M. E., Ferrer, J.-L., Anisfeld, A. M., Edwards, P. A., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00104-7 · Cited by 390
Oelkers, P., Kirby, L. C., Heubi, J. E., & Dawson, P. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119355 · Cited by 385
Dawson, P. A., Hubbert, M., Haywood, J., Craddock, A. L., Zerangue, N., Christian, W. V., & Ballatori, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412752200 · Cited by 381
Sulfotransferase molecular biology: cDNAs and genes
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034160 · Cited by 369
Zollner, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22646 · Cited by 362
A Mouse Model of Hepatocellular Carcinoma
Nicholes, K., Guillet, S., Tomlinson, E., Hillan, K., Wright, B., Frantz, G. D., Pham, T. A., Dillard-Telm, L., Tsai, S. P., Stephan, J.-P., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61177-7 · Cited by 359
Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice
Kim, I., Morimura, K., Shah, Y., Yang, Q., Ward, J. M., & Gonzalez, F. J. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl249 · Cited by 357
Self-citationIdentification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene
Grober, J., Zaghini, I., Fujii, H., Jones, S. A., Kliewer, S. A., Willson, T. M., Ono, T., & Besnard, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29749 · Cited by 353
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model
Moschetta, A., Bookout, A. L., & Mangelsdorf, D. J. (2004) · Nature Medicine · doi:10.1038/nm1138 · Cited by 325
FGF-19, A NOVEL FIBROBLAST GROWTH FACTOR WITH UNIQUE SPECIFICITY FOR FGFR4
Xie, M.-H., Holcomb, I., Deuel, B., Dowd, P., Huang, A., Vagts, A., Foster, J., Liang, J., Brush, J., Gu, Q., et al. (1999) · Cytokine · doi:10.1006/cyto.1999.0485 · Cited by 301
Identification of a hormonal basis for gallbladder filling
Choi, M., Moschetta, A., Bookout, A. L., Peng, L., Umetani, M., Holmstrom, S. R., Suino-Powell, K., Xu, H. E., Richardson, J. A., Gerard, R. D., et al. (2006) · Nature Medicine · doi:10.1038/nm1501 · Cited by 294
Plass, J. R. M., Mol, O., Heegsma, J., Geuken, M., Faber, K. N., Jansen, P. L. M., & Müller, M. (2002) · Hepatology · doi:10.1053/jhep.2002.31724 · Cited by 290
Carter, B. A., Taylor, O. A., Prendergast, D. R., Zimmerman, T. L., Von Furstenberg, R., Moore, D. D., & Karpen, S. J. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3181256492 · Cited by 286
Hughes, S. E. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500710 · Cited by 280
Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism
Eloranta, J. J., & Kullak-Ublick, G. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.019 · Cited by 260
van Mil, S. W. C., Milona, A., Dixon, P. H., Mullenbach, R., Geenes, V. L., Chambers, J., Shevchuk, V., Moore, G. E., Lammert, F., Glantz, A. G., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.015 · Cited by 257
Chen, F., Ma, L., Dawson, P. A., Sinal, C. J., Sehayek, E., Gonzalez, F. J., Breslow, J., Ananthanarayanan, M., & Shneider, B. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207903200 · Cited by 253
Self-citationFarnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3
Huang, L., Zhao, A., Lew, J.-L., Zhang, T., Hrywna, Y., Thompson, J. R., de Pedro, N., Royo, I., Blevins, R. A., Peláez, F., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308321200 · Cited by 248
Transcriptional Regulation of the Human Sterol 12α-Hydroxylase Gene (CYP8B1)
Zhang, M., & Chiang, J. Y. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105117200 · Cited by 247
Cui, J., Huang, L., Zhao, A., Lew, J.-L., Yu, J., Sahoo, S., Meinke, P. T., Royo, I., Peláez, F., & Wright, S. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209323200 · Cited by 246
Nuclear Bile Acid Receptor FXR Protects against Intestinal Tumorigenesis
Modica, S., Murzilli, S., Salvatore, L., Schmidt, D. R., & Moschetta, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1791 · Cited by 237
Stieger, B., Meier, Y., & Meier, P. J. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0152-8 · Cited by 235
Bile acid-induced negative feedback regulation of the human ileal bile acid transporter
Neimark, E., Chen, F., Li, X., & Shneider, B. L. (2004) · Hepatology · doi:10.1002/hep.20295 · Cited by 234
Li, T., Matozel, M., Boehme, S., Kong, B., Nilsson, L.-M., Guo, G., Ellis, E., & Chiang, J. Y. L. (2011) · Hepatology · doi:10.1002/hep.24107 · Cited by 224
In situ localization of the hepatocytic na+/taurocholate cotransporting polypeptide in rat liver
Stieger, B., Hagenbuch, B., Landmann, L., Höchli, M., Schroeder, A., & Meier, P. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90821-4 · Cited by 223
Maran, R. R. M., Thomas, A., Roth, M., Sheng, Z., Esterly, N., Pinson, D., Gao, X., Zhang, Y., Ganapathy, V., Gonzalez, F. J., et al. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145409 · Cited by 220
Self-citationThe Farnesoid X Receptor Controls Gene Expression in a Ligand- and Promoter-selective Fashion
Lew, J.-L., Zhao, A., Yu, J., Huang, L., de Pedro, N., Peláez, F., Wright, S. D., & Cui, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306422200 · Cited by 213
Gonzalez, F. J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012492 · Cited by 213
Self-citationDe Fabiani, E., Mitro, N., Gilardi, F., Caruso, D., Galli, G., & Crestani, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305079200 · Cited by 210
Dehydroepiandrosterone Sulfotransferase Gene Induction by Bile Acid Activated Farnesoid X Receptor
Song, C. S., Echchgadda, I., Baek, B.-S., Ahn, S. C., Oh, T., Roy, A. K., & Chatterjee, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107557200 · Cited by 208
Genome‐wide tissue‐specific farnesoid X receptor binding in mouse liver and intestine†
Thomas, A. M., Hart, S. N., Kong, B., Fang, J., Zhong, X., & Guo, G. L. (2010) · Hepatology · doi:10.1002/hep.23450 · Cited by 205
Barbier, O., Torra, I. P., Sirvent, A., Claudel, T., Blanquart, C., Duran-Sandoval, D., Kuipers, F., Kosykh, V., Fruchart, J.-C., & Staels, B. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00388-3 · Cited by 204
Farnesoid X Receptor Regulates Bile Acid-Amino Acid Conjugation
Pircher, P. C., Kitto, J. L., Petrowski, M. L., Tangirala, R. K., Bischoff, E. D., Schulman, I. G., & Westin, S. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302128200 · Cited by 198
Fiorucci, S., Clerici, C., Antonelli, E., Orlandi, S., Goodwin, B., Sadeghpour, B. M., Sabatino, G., Russo, G., Castellani, D., Willson, T. M., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079665 · Cited by 196
Pellicciari, R., Costantino, G., Camaioni, E., Sadeghpour, B. M., Entrena, A., Willson, T. M., Fiorucci, S., Clerici, C., & Gioiello, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049904b · Cited by 194
Zollner, G., Fickert, P., Fuchsbichler, A., Silbert, D., Wagner, M., Arbeiter, S., Gonzalez, F. J., Marschall, H.-U., Zatloukal, K., Denk, H., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00228-9 · Cited by 193
Self-citationThe bile acid sensor FXR regulates insulin transcription and secretion
Renga, B., Mencarelli, A., Vavassori, P., Brancaleone, V., & Fiorucci, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.01.002 · Cited by 189
De Fabiani, E., Mitro, N., Anzulovich, A. C., Pinelli, A., Galli, G., & Crestani, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103270200 · Cited by 184
Fiorucci, S., Rizzo, G., Antonelli, E., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pruzanski, M., Morelli, A., & Pellicciari, R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084905 · Cited by 183
FXR regulates organic solute transporters α and β in the adrenal gland, kidney, and intestine
Lee, H., Zhang, Y., Lee, F. Y., Nelson, S. F., Gonzalez, F. J., & Edwards, P. A. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500417-jlr200 · Cited by 178
Self-citationZollner, G., Wagner, M., Moustafa, T., Fickert, P., Silbert, D., Gumhold, J., Fuchsbichler, A., Halilbasic, E., Denk, H., Marschall, H.-U., et al. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00490.2005 · Cited by 178
Gnerre, C., Bl??ttler, S., Kaufmann, M. R., Looser, R., & Meyer, U. A. (2004) · Pharmacogenetics · doi:10.1097/00008571-200410000-00001 · Cited by 173
Jung, D., Podvinec, M., Meyer, U. A., Mangelsdorf, D. J., Fried, M., Meier, P. J., & Kullak–Ublick, G. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.33583 · Cited by 170
Benefit of farnesoid X receptor inhibition in obstructive cholestasis
Stedman, C., Liddle, C., Coulter, S., Sonoda, J., Alvarez, J. G., Evans, R. M., & Downes, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604772103 · Cited by 170
Flatt, B., Martin, R., Wang, T.-L., Mahaney, P., Murphy, B., Gu, X.-H., Foster, P., Li, J., Pircher, P., Petrowski, M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8014124 · Cited by 163
Cheng, J., Shah, Y. M., Ma, X., Pang, X., Tanaka, T., Kodama, T., Krausz, K. W., & Gonzalez, F. J. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170225 · Cited by 163
Self-citationDüfer, M., Hörth, K., Wagner, R., Schittenhelm, B., Prowald, S., Wagner, T. F. J., Oberwinkler, J., Lukowski, R., Gonzalez, F. J., Krippeit-Drews, P., et al. (2012) · Diabetes · doi:10.2337/db11-0815 · Cited by 161
Self-citationIntestinal Bile Acid Transport: Biology, Physiology, and Pathophysiology
Shneider, B. L. (2001) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2001.tb07287.x · Cited by 159
Araya, Z., & Wikvall, K. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00031-1 · Cited by 156
Akwabi-Ameyaw, A., Bass, J. Y., Caldwell, R. D., Caravella, J. A., Chen, L., Creech, K. L., Deaton, D. N., Jones, S. A., Kaldor, I. W., Liu, Y., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.073 · Cited by 151
Organic Anion Transporting Polypeptides (OATPs): Regulation of Expression and Function
Svoboda, M., Riha, J., Wlcek, K., Jaeger, W., & Thalhammer, T. (2011) · Current Drug Metabolism · doi:10.2174/138920011795016863 · Cited by 143
Ricketts, M., Boekschoten, M. V., Kreeft, A. J., Hooiveld, G. J. E. J., Moen, C. J. A., Müller, M. M., Frants, R. R., Kasanmoentalib, S., Post, S. M., Princen, H. M. G., et al. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0133 · Cited by 143
Novel pathways of bile acid metabolism involving CYP3A4
Bodin, K., Lindbom, U., & Diczfalusy, U. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.11.003 · Cited by 141
Intestinal First-Pass Metabolism of CYP3A4 Substrates
Kato, M. (2008) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.23.87 · Cited by 141
Eloranta, J. J., Jung, D., & Kullak-Ublick, G. A. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0159 · Cited by 139
Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis
Anakk, S., 渡辺, 光., Ochsner, S. A., McKenna, N. J., Finegold, M. J., & Moore, D. D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42846 · Cited by 134
del Castillo‐Olivares, A., & Gil, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000996200 · Cited by 133
Polyunsaturated Fatty Acids Are FXR Ligands and Differentially Regulate Expression of FXR Targets
Zhao, A., Yu, J., Lew, J.-L., Huang, L., Wright, S. D., & Cui, J. (2004) · DNA and Cell Biology · doi:10.1089/1044549041562267 · Cited by 130
Roles of FGF19 in Liver MetabolismPreprint
Kır, S., Kliewer, S. A., & Mangelsdorf, D. J. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010710 · Cited by 128
Nozawa, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.159 · Cited by 126
Kramer, W., Girbig, F., Gutjahr, U., Kowalewski, S., Jouvenal, K., Müller, G. A., TRIPIER, D., & Wess, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46808-6 · Cited by 116
Jung, D., Hagenbuch, B., Fried, M., Meier, P. J., & Kullak-Ublick, G. A. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00456.2003 · Cited by 116
Mini-Review: Endocrine Actions of Fibroblast Growth Factor 19
Jones, S. A. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700105z · Cited by 115
Chen, W., Owsley, E., Yang, Y., Stroup, D., & Chiang, J. Y. L. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30272-8 · Cited by 112
Hepatocyte Nuclear Factor 4α Is a Central Regulator of Bile Acid Conjugation
Inoue, Y., Yu, A., Inoue, J., & Gonzalez, F. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311015200 · Cited by 112
Self-citationLiu, N., Meng, Z., Lou, G., Zhou, W., Wang, X., Zhang, Y., Zhang, L., Liu, X., Yen, Y., Lai, L. L., et al. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1383 · Cited by 111
Identification of Gene-selective Modulators of the Bile Acid Receptor FXR
Dussault, I., Beard, R., Lin, M., Hollister, K., Chen, J., Xiao, J. H., Chandraratna, R., & FORMAN, B. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209863200 · Cited by 106
Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1
Chong, H. K., Infante, A. M., Seo, Y., Jeon, T. I., Zhang, Y., Edwards, P. A., Xie, X. S., & Osborne, T. F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq397 · Cited by 98
Nicolaou, K. C., Evans, R. M., Roecker, A. J., Hughes, R. O., Downes, M., & Pfefferkorn, J. A. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b300525a · Cited by 95
Lee, F. Y., Vallim, T. Q. D. A., Chong, H. K., Zhang, Y., Liu, Y., Jones, S. A., Osborne, T. F., & Edwards, P. A. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0117 · Cited by 94
Primary Bile Acid Malabsorption: Defective In Vitro Ileal Active Bile Acid Transport
Heubi, J. E., Balistreri, W. F., Fondacaro, J. D., Partin, J. C., & Schubert, W. K. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80009-7 · Cited by 93
FXR an emerging therapeutic target for the treatment of atherosclerosis
Mencarelli, A., & Fiorucci, S. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00997.x · Cited by 92
Chen, W., & Chiang, J. Y. L. (2003) · Gene · doi:10.1016/s0378-1119(03)00631-0 · Cited by 90
The Nuclear Hormone Receptor Farnesoid X Receptor (FXR) Is Activated by Androsterone
Wang, S., Lai, K., Moy, F. J., Bhat, A., Hartman, H. B., & Evans, M. J. (2006) · Endocrinology · doi:10.1210/en.2005-1485 · Cited by 90
Pillot, T., Ouzzine, M., Fournel‐Gigleux, S., Lafaurie, C., Radominska-p, A., Burchell, B., Siest, G., & Magdalou, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74437-8 · Cited by 88
FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade
Li, H., Frank, C., Shang, Q., Pan, L., Shneider, B. L., Chiang, J. Y. L., FORMAN, B. M., Ananthanarayanan, M., Tint, G. S., Salen, G., et al. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00170.2004 · Cited by 88
Sinha, J., Chen, F., Miloh, T., Burns, R. C., Zhisheng, Y., & Shneider, B. L. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90343.2008 · Cited by 88
Bu, H. (2006) · Current Drug Metabolism · doi:10.2174/138920006776359329 · Cited by 87
Zhang, Y., Gong, W., Dai, S.-S., Huang, G., Shen, X., Gao, M., Xu, Z., Zeng, Y., & He, F. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0473 · Cited by 85
Kovacs, P. L., Kress, R., Rocha, J., Kurtz, U., Miquel, J. F., Nervi, F. O., Méndez‐Sánchez, N., Uribe, M., Bock, H. H., Schirin-Sokhan, R., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.027 · Cited by 84
del Castillo‐Olivares, A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.18.3587 · Cited by 81
Lee, J., Seok, S., Yu, P., Kim, K., Smith, Z., Rivas‐Astroza, M., Zhong, S., & Kemper, J. K. (2012) · Hepatology · doi:10.1002/hep.25609 · Cited by 78
Mason, A. L., Luketic, V. A., Lindor, K., Hirschfield, G. M., Gordon, S., Mayo, M. J., Kowdley, K. V., Parés, A. R., Trauner, M. A., CASTELLOE, E. N., et al. (2010) · Journal of Hepatology · doi:10.1016/s0168-8278(10)60004-9 · Cited by 77
Khan, A. A., Chow, E. C. Y., van Loenen-Weemaes, A. M., Porte, R. J., Pang, K. S., & Groothuis, G. M. M. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.01.006 · Cited by 75
Arrese, M. A., Trauner, M. A., Sacchiero, R. J., Crossman, M. W., & Shneider, B. L. (1998) · Hepatology · doi:10.1002/hep.510280424 · Cited by 68
Howard, W. R., Pospisil, J. A., Njolito, E., & Noonan, D. J. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8869 · Cited by 67
Sepe, V., Bifulco, G., Renga, B., D’Amore, C., Fiorucci, S., & Zampella, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101336m · Cited by 67
Deng, R., Yang, D., Yang, J., & Yan, B. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097758 · Cited by 65
Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation
Chanda, D., Xie, Y., & Choi, H.-S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq227 · Cited by 61
Bass, J. Y., Caravella, J. A., Chen, L., Creech, K. L., Deaton, D. N., Madauss, K. P., Marr, H. B., McFadyen, R. B., Miller, A. B., Mills, W. Y., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.089 · Cited by 60
Lu, Y. F., Heydel, J., Li, X., Bratton, S. M., Lindblom, T. H., & Radominska-p, A. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003061 · Cited by 58
Tuberatolides, Potent FXR Antagonists from the Korean Marine Tunicate Botryllus tuberatus
Choi, H., Hwang, H., Chin, J., Kim, E., Lee, J., Nam, S., Lee, B. C., Rho, B. J., & Kang, H. (2010) · Journal of Natural Products · doi:10.1021/np100489u · Cited by 57
Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonist
Feng, S., Yang, M., Zhang, Z., Wang, Z., Hong, D., Richter, H. G., Benson, G. M., Bleicher, K., Grether, U., Martin, R. E., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.008 · Cited by 55
An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis
Komm, B. S., & Chines, A. A. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.11.018 · Cited by 55
Analysis of bile acid‐induced regulation of FXR target genes in human liver slices
Jung, D., Elferink, M. G. L., Stellaard, F., & Groothuis, G. M. M. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01393.x · Cited by 53
Niesor, E. J., Flach, J., Antoni, I., Perez, A., & Bentzen, C. L. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013398185 · Cited by 49
Nuclear Receptors in Nonalcoholic Fatty Liver Disease
López-Velázquez, J. A., Carrillo-Córdova, L. D., Chávez-Tapia, N. C., Uribe, M., & Méndez-Sánchez, N. (2012) · Journal of Lipids · doi:10.1155/2012/139875 · Cited by 48
Differential Modulation of Farnesoid X Receptor Signaling Pathway by the Thiazolidinediones
Kaimal, R., Song, X., Yan, B., King, R. J., & Deng, R. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.151233 · Cited by 45
Campana, G., Pasini, P., Roda, A., & Spampinato, S. M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.019 · Cited by 44
Miao, J., Choi, S., Seok, S. M., Yang, L. C., Zuercher, W. J., Xu, Y., Willson, T. M., Xu, H. E., & Kemper, J. K. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0033 · Cited by 44
Cho, J., Matsubara, T., Kang, D. W., Ahn, S., Krausz, K. W., Idle, J. R., Luecke, H. F., & Gonzalez, F. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m002923 · Cited by 44
Self-citationCoppola, C. P., Gosche, J. R., Arrese, M. A., Ancowitz, B. A., MADSEN, J., Vanderhoof, J. A., & Shneider, B. L. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70088-5 · Cited by 43
Gioiello, A., Macchiarulo, A., Carotti, A., Filipponi, P., Costantino, G., Rizzo, G., Adorini, L., & Pellicciari, R. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.004 · Cited by 43
Kainuma, M., Kasuga, J.-I., Hosoda, S., Wakabayashi, K.-I., Tanatani, A., Nagasawa, K., Miyachi, H., Makishima, M., & Hashimoto, Y. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.075 · Cited by 42
Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist
Kainuma, M., Makishima, M., Hashimoto, Y., & Miyachi, H. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.046 · Cited by 41
Miyata, M., Matsuda, Y., Tsuchiya, H., Kitada, H., Akase, T., Shimada, M., Nagata, K., Gonzalez, F. J., & Yamazoe, Y. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.315 · Cited by 38
Self-citationMiyata, M., Tozawa, A., Otsuka, H., Nakamura, T., Nagata, K., Gonzalez, F. J., & Yamazoe, Y. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076158 · Cited by 37
Self-citationSuzuki, T., Tamehiro, N., Sato, Y., Kobayashi, T., Ishii‐Watabe, A., Shinozaki, Y., Nishimaki‐Mogami, T., Hashimoto, T., Asakawa, Y., Inoue, K., et al. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08006fp · Cited by 36
Iguchi, Y., Yamaguchi, M., Sato, H., Kihira, K., Nishimaki‐Mogami, T., & Une, M. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m004051 · Cited by 34
Deng, G., Li, W., Shen, J., Jiang, H., Chen, K., & Liu, H. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.027 · Cited by 30
Functional analysis of the promoter of human sterol 27-hydroxylase gene in HepG2 cells
Garuti, R., Croce, M. A., Piccinini, L., Tiozzo, R., Bertolini, S., & Calandra, S. (2002) · Gene · doi:10.1016/s0378-1119(01)00874-5 · Cited by 29
5α-Bile alcohols function as farnesoid X receptor antagonists
Nishimaki‐Mogami, T., Kawahara, Y., Tamehiro, N., Yoshida, T., Inoue, K., Ohno, Y., Nagao, T., & Une, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.027 · Cited by 23
Morelli, A., Vignozzi, L., Maggi, M., & Adorini, L. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.10.013 · Cited by 18
Rifaximin for Inflammatory Bowel Disease
Guslandi, M. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1245-y · Cited by 5
Cited by
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Pleiotropic Roles of Bile Acids in Metabolism
de Aguiar Vallim, T. Q., Tarling, E. J., & Edwards, P. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.013 · Cited by 1,209
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Sun, L., Xie, C., Wang, G., Wu, Y., Wu, Q., Wang, X., Liu, J., Deng, Y., Xia, J., Chen, B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0222-4 · Cited by 1,011
Self-citationDiet and feeding pattern affect the diurnal dynamics of the gut microbiome
Zarrinpar, A., Chaix, A., Yooseph, S., & Panda, S. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.11.008 · Cited by 926
Metadata
- Authors
- Matsubara, T., Li, F., & Gonzalez, F. J.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 368
- Issue
- 1-2
- Pages
- 17-29
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W2117616183
- Cited by
- 381
- References
- 148
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.